Irwin Simon did not dilute us 240 million sharesWe approved access to that amount should be need it for a lucrative acquisition. That doesn't mean a major partner with capital doesn't join us and we fill our war chest that way. It's just means we don't require that should we see an attractive acquisition we have the firepower ourselves. In return for the diluted shares like the 9 million we paid for MedMen. We receive more value in return from
whstever Irwin picks. No one can deny the history of our great buys. CC pharma Sweetwater for example